Cephalon's Nuvigil Jet Lag Indication Grounded By Complete Response Letter
This article was originally published in The Pink Sheet Daily
Executive Summary
Wall Street analysts question the extent to which the FDA move is a setback, given the outlook for the company's wakefulness franchise.